Head-to-head comparisons of [ 68 Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study.
Zhi-Bin KeShao-Ming ChenJia-Yin ChenShao-Hao ChenQi YouJiang-Bo SunYu-Ting XueXiong-Lin SunXiao-Hui WuQing-Shui ZhengYong WeiXue-Yi XueNing XuPublished in: European journal of nuclear medicine and molecular imaging (2022)
Ga]Ga-PSMA-11 PET/CT was used as a therapeutic response assessment tool.